Comparison of in vitro and in vivo inhibition potencies of fluvoxamine toward CYP2C19. | Drug Metab Dispos;31(5): 565-71, 2003 May. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Comparison of in vitro and in vivo inhibition potencies of fluvoxamine toward CYP2C19.

Yao, Caiping; Kunze, Kent L; Trager, William F; Kharasch, Evan D; Levy, René H.

Affiliation

Yao C; Department of Pharmaceutics, University of Washington, Seattle, Washington 98195-7610, USA.

Drug Metab Dispos ; 31(5): 565-71, 2003 May.

Article in En | MEDLINE | ID: mdl-12695344

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Aryl Hydrocarbon Hydroxylases / Fluvoxamine / Enzyme Inhibitors / Mixed Function Oxygenases / Mephenytoin Type of study: Prognostic_studies Limits: Humans Language: En Journal: Drug Metab Dispos Journal subject: FARMACOLOGIA Year: 2003 Document type: Article Affiliation country:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Aryl Hydrocarbon Hydroxylases / Fluvoxamine / Enzyme Inhibitors / Mixed Function Oxygenases / Mephenytoin Type of study: Prognostic_studies Limits: Humans Language: En Journal: Drug Metab Dispos Journal subject: FARMACOLOGIA Year: 2003 Document type: Article Affiliation country: